These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 5859903)

  • 61. Pyrazinamide deamidase activity in tuberculous disease.
    Gurumurthy P; Krishnamurthy PV; Garhupati Sarma G
    Am Rev Respir Dis; 1981 Jul; 124(1):97. PubMed ID: 7020509
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Clinical results of piazofoline therapy in pulmonary tuberculosis].
    Deodato M
    Minerva Med; 1965 Sep; 56(71):2897-8. PubMed ID: 5322271
    [No Abstract]   [Full Text] [Related]  

  • 63. [Studies of the therapeutical effects and intolerance levels of morphazinamide in pulmonary tuberculosis].
    Ruiz Benítez G; Bonilla C
    Rev Clin Esp; 1967 Apr; 105(1):28-37. PubMed ID: 5613422
    [No Abstract]   [Full Text] [Related]  

  • 64. [Antitubercular chemotherapy].
    Jouveshomme S; Dautzenberg B
    Rev Mal Respir; 1997 Dec; 14 Suppl 5():S88-104. PubMed ID: 9496594
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [MORPHAZINAMIDE IN ANTUBERCULAR THERAPY].
    FOUQUET J; TEYSSIER L
    G Ital Chemioter; 1963; 10():164-70. PubMed ID: 14079399
    [No Abstract]   [Full Text] [Related]  

  • 66. [Effectiveness of chemotherapy of intrathoracic tuberculosis in children: late follow-up data].
    Iukhimenko NV
    Probl Tuberk; 2001; (5):19-22. PubMed ID: 11588952
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
    East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Tuberculosis of the middle ear: a rare extrapulmonary manifestation].
    Schütte W; Berghaus A; Schütte A
    Dtsch Med Wochenschr; 1996 Dec; 121(49):1551. PubMed ID: 8998926
    [No Abstract]   [Full Text] [Related]  

  • 69. The clearance of theophylline is increased during the initial period of tuberculosis treatment.
    Ahn HC; Lee YC
    Int J Tuberc Lung Dis; 2003 Jun; 7(6):587-91. PubMed ID: 12797703
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [PRELIMINARY FUNCTIONAL AND MORPHOLOGICAL HEPATIC FINDINGS IN PATIENTS TREATED WITH MORPHAZINAMIDE].
    GRECO S; DUSI U; MENOZZI V
    Riv Anat Patol Oncol; 1963 May; 23():LXVII-LXXII. PubMed ID: 14083537
    [No Abstract]   [Full Text] [Related]  

  • 71. [THE THERAPY OF PULMONARY TUBERCULOSIS WITH MORPHAZINAMIDE. CLINICAL CONTRIBUTION].
    MIGLIOLI S; CALABRESE L
    Clin Ter; 1963 Aug; 26():301-10. PubMed ID: 14060210
    [No Abstract]   [Full Text] [Related]  

  • 72. [Clinical experiences with morphazinamide administered in slow venous perfusion in the treatment of pulmonary tuberculosis].
    Censi G; Orlandini GC
    Minerva Med; 1965 Sep; 56(71):2881-92. PubMed ID: 5322269
    [No Abstract]   [Full Text] [Related]  

  • 73. [Problems of post-sanatorial antimycobacterial treatment].
    Corda M
    Minerva Med; 1965 Sep; 56(70):2827-31. PubMed ID: 5852641
    [No Abstract]   [Full Text] [Related]  

  • 74. Comparison of the antituberculous activity of morphazinamide and pyrazinamide on chronic experimental tuberculosis. II. The emergence of resistance and its retardation in the course of monotherapy and combinations of antituberculous drugs.
    Havel A; Trnka L; Kuska J
    Chemotherapia (Basel); 1964-1965; 9(3):168-75. PubMed ID: 4953658
    [No Abstract]   [Full Text] [Related]  

  • 75. Pyrazinamide.
    Tuberculosis (Edinb); 2008 Mar; 88(2):141-4. PubMed ID: 18486055
    [No Abstract]   [Full Text] [Related]  

  • 76. [Morphazinamide by venous perfusion in therapy of pulmonary tuberculosis].
    Leoncini G; Bolondi O; Costi TF
    Minerva Med; 1965 Sep; 56(71):2910-3. PubMed ID: 5322275
    [No Abstract]   [Full Text] [Related]  

  • 77. Side effects of antituberculosis therapy.
    Leung CC; Chan CK; Yew WW
    Am J Respir Crit Care Med; 2004 May; 169(10):1168-9; author reply 1169. PubMed ID: 15132966
    [No Abstract]   [Full Text] [Related]  

  • 78. [Intravenous and topical use of morphazinamide in the pre- and post-operative treatment of pulmonary and pleural tuberculosis].
    Maggio L; Tabocchini W
    Minerva Med; 1965 Sep; 56(70):2797-809. PubMed ID: 5853905
    [No Abstract]   [Full Text] [Related]  

  • 79. [Morphazinamide in the treatment of urogenital tuberculosis in a sanatorium. 1st trials].
    Kalachnikoff P; Laugie H; Lengrand J
    J Urol Nephrol (Paris); 1966; 72(10):756-61. PubMed ID: 5972482
    [No Abstract]   [Full Text] [Related]  

  • 80. [Effects of morphazinamide in monomedicamentous therapy per os and intravenously in pulmonary tuberculosis].
    Sorrentino F; Calagna L
    Minerva Med; 1965 Sep; 56(71):2938-42. PubMed ID: 5322280
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.